This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Rhythm Pharmaceuticals drug Imcivree met the body mass index reduction goals of a Phase 3 test in hypothalamic obesity, an acquired form of obesity stemming from dysregulation of the MC4R pathway in the hypothalamus. The engineered peptide drug is already approved for two genetically driven types of obesity. The post Rhythm Pharma Drug Lowers BMI in Rare Form of Obesity Rooted in a Dysregulated Brain Pathway appeared first on MedCity News.
As healthcare professionals, we know firsthand how demanding and rewarding our careers can be. But between long shifts, continuing education, and patient care, theres often little time left to focus on something equally important: your financial future. Thats the benefit of InCrowd surveys. You are able to earn extra income simply by sharing your professional insights all on your own schedule.
GSK is licensing an ABL Bio technology yields bispecific antibodies engineered to leverage a certain transmembrane receptor to cross the blood-brain barrier to treat neurodegeneration. GSK is already partnered with Alector, which has monoclonal antibodies in clinical development for Alzheimers disease. The post GSK Grabs Rights to Technology That Gets Drugs Across the Blood-Brain Barrier appeared first on MedCity News.
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
Poverty significantly impacts the mental and physical health of older adults. Lack of access to care and unaddressed SDOH issues lead to poorly managed chronic conditions, delays in treatment, medication non-adherence, and lower utilization of preventive services. The post The Crisis of Elderly Poverty and Its Health Consequences appeared first on MedCity News.
How do pharma brands cut through the noise and bring the right audiences to their digital doorstep? As digital channels continue to expand, identifying and optimizing the best traffic drivers has become more critical than ever for pharma marketing teams. In this article, well unpack the most effective sources of website traffic in 2025from organic search to paid campaignsand explore how marketing leaders can turn clicks into meaningful engagement.
How do pharma brands cut through the noise and bring the right audiences to their digital doorstep? As digital channels continue to expand, identifying and optimizing the best traffic drivers has become more critical than ever for pharma marketing teams. In this article, well unpack the most effective sources of website traffic in 2025from organic search to paid campaignsand explore how marketing leaders can turn clicks into meaningful engagement.
Healthcare leaders hope Dr. Oz supports Medicare Advantage, nutrition and telehealth as CMS administrator. The post What Issues Do Healthcare Leaders Want Dr. Oz to Tackle as CMS Administrator? appeared first on MedCity News.
If youre still evaluating benefits the same way you did five years ago, youre already behind. Here are some ways to get ahead. The post Six for 26: Top Concerns for Benefits Leaders Heading into 2026 Planning appeared first on MedCity News.
An innovative air sampling system could improve the efficiency and accuracy of rapid detection for airborne bacteria in the environment, new research suggests. Eraslan-Gltekin et al. developed an air sampling system to collect aerosolised bacterial samples in a liquid medium. By utilising an improved air sampler with loop-mediated isothermal amplification (LAMP) as a rapid nucleic acid amplification method, the proposed method provides a cost-effective and reliable approach to monitoring airborn
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
Can Automating Patient Intake Help Healthcare Providers? Manual patient intake is a burden. Its slow and prone to errors. This can mean long wait times for patients, but for healthcare providers, it can mean missing data, extra costs, and compliance risks. Automation solves the problem by streamlining data capture, improving accuracy, and increasing security.
As single use becomes more prevalent, end users are looking for more customization, and regulators are refining their rules, says Todd Andrews of CPC in an interview with Pharmaceutical Technology Group.
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
The Scottish Medicines Consortium (SMC) has approved bimekizumab for adults with active moderate to severe hidradenitis suppurativa (HS) who have not responded to conventional systemic therapies. This approval makes Scotland the first country in the UK to offer bimekizumab for HS patients. HS is a chronic inflammatory skin condition affecting 0.77% of the UK population.
In the second part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Kimberly Westrich, chief strategy officer at the National Pharmaceutical Council, describes how accumulators, maximizers, and AFPs are impacting patients, manufacturers, and healthcare ecosystems, and how that all ties into the presentation she participated in.
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
Tirzepatide-treated patients with chronic kidney disease (CKD), obesity, and heart failure with preserved ejection fraction (HFpEF) had improved renal function both by cystatin C and creatinine.
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
New facility is expected to serve as a global hub for accelerating the development of next-generation antibody-drug conjugates for the treatment of cancer.
Dean Bornilla, Pace Life Sciences, highlights his organization's future role in supporting biopharmaceutical development and manufacturing coast-to-coast.
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Following the launch of the first disease-modifying therapies for Alzheimers disease, a key theme at the AD/PD 2025 International Conference on Alzheimers and Parkinsons Diseases has (AD/PD) been on their real-world use.
Medical affairs is transforming into a strategic hub, integrating real-world data and digital insights to bridge research and clinical application, enabling evidence-based healthcare decisions and aligning with patient and professional needs.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
241 
Let's personalize your content